Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.490
+0.030 (2.05%)
Jun 12, 2025, 11:23 AM - Market open
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $91.47 million as of June 12, 2025. Its market cap has decreased by -88.09% in one year.
Market Cap
91.47M
Enterprise Value
-155.85M
1-Year Change
-88.09%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $91.47M, a decrease of -87.60%. That is a compound annual growth rate of -34.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 89.62M | -88.82% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |